ACADIA PHARMACEUTICALS INC.
Revenue Breakdown
| Fiscal Year | Collaborative and license revenue | NUPLAZID net product sales | DAYBUE net product sales |
|---|---|---|---|
| FY2006 | $4.4M | $0 | $0 |
| FY2007 | $4.0M | $0 | $0 |
| FY2008 | $1.9M | $0 | $0 |
| FY2009 | $1.4M | $0 | $0 |
| FY2010 | $143.0K | $0 | $0 |
| FY2011 | $0 | $0 | $0 |
| FY2012 | $0 | $0 | $0 |
| FY2013 | $0 | $0 | $0 |
| FY2014 | $0 | $0 | $0 |
| FY2015 | $0 | $0 | $0 |
| FY2016 | $0 | $17.3M | $0 |
| FY2017 | $0 | $124.9M | $0 |
| FY2018 | $0 | $223.8M | $0 |
| FY2019 | $0 | $339.1M | $0 |
| FY2020 | $0 | $441.8M | $0 |
| FY2021 | $0 | $484.1M | $0 |
| FY2022 | $0 | $517.2M | $0 |
| FY2023 | $0 | $549.2M | $177.2M |